InvestorsHub Logo
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Re: opportunityknocking post# 26701

Saturday, 07/03/2010 5:12:09 PM

Saturday, July 03, 2010 5:12:09 PM

Post# of 30387
Opportunity, I know you do not like me posting on this board but here is your answer.

Moro could in fact submit a 510k for approval to monitor colon cancer but first, he would be required to rund some FDA approved clinical trials to prove in fact that DR70 was in fact a predicate for RECAF. DR70 is approved for serial monitoring. That is just not a single one time test so the trials would not just simple one time tests.

To monitor colon cancer, multiple DR70 tests are given over a period of time looking for an increase in the level of Fibrin degradation products.

Until Moro decides to run any trials, there can be no submission of a 510k.

Now, lets examine DR70 or Onko Sure as it is now called. It has been approved to monitor colon cancer for two years and in that time, it has not been able to develop any market at all for the stated use. In fact, RPC has stated in filings that the sales in the US are not significant at all and they indicate their intentions to do no marketing in the US.

You speak of the large increase in the stock price of RPC. The huge increase in the share price was sparked by their announcement of a collaboration to develop their CIT technology. In their filings, they state that a lawsuit was filed in 2004 by Accuvector stating they still owned the patent. If you look at the patent, RPC was forced by a Canadian court to make an assignment of the patent back to Accuvector. That assignment was followed by an assignment of any interest that remained with Dr. Chang to RPC. The net result is that if Dr. Chang indeed had no interest remaining after his initial license to Accuvector, then RPC would have nothing but a lawsuit agianst Dr. Chang. No legitimate company would even attempt to develop the technology with the current patent status.

Now as for the current collaboration in India for the CIT technology, it is by a Indian citizen that was the CEO of a corporation that went out of business in 2008. There is no information on what Gaur Diagno is doing nor the other company he has called Jaiva Technologies. I truly suspect that nothing will ever come of any development of the technology. RPC just needed a pump and they got it.

GoldSeekerâ„¢

I have never shorted nor intend to have any financial interest in BOCX. I am not connected with anyone who trades, shorts or has financial interests in BOCX. I only post facts and my opinions. I do not post on IHUB with different aliases.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.